AI assistant
Sending…
Coloplast — Director's Dealing 2018
May 23, 2018
3358_rpt_2018-05-23_44a713a4-26fa-45ea-a771-9c854d1237de.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Nasdaq Copenhagen
23 May 2018
Coloplast A/S Holtedam 1 3050 Humlebæk Denmark Tel: +45 4911 1111 www.coloplast.com CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns sale of shares.
| Name | Anders Lonning-Skovgaard |
|---|---|
| Reason | CFO & Executive Vice President |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Sale of shares |
| Trade date | 22 February 2018 |
| Market | Nasdaq Copenhagen |
| Number | 18,693 |
| Share price in DKK | 613.55 |
| Market value in DKK | 11,469,109.70 |
Kind regards, Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Anne-Sofie Søegaard, tel. +45 4911 1924.
More from Coloplast
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23